The autopsy is not dead: ongoing relevance of the autopsy.

B cell lymphoma Clear cell carcinoma of ovary Guillain-Barré syndrome hypercoagulability

Journal

Autopsy & case reports
ISSN: 2236-1960
Titre abrégé: Autops Case Rep
Pays: Brazil
ID NLM: 101640070

Informations de publication

Date de publication:
2023
Historique:
received: 04 01 2023
accepted: 10 03 2023
medline: 9 6 2023
pubmed: 9 6 2023
entrez: 9 6 2023
Statut: epublish

Résumé

Autopsy requests have been trending downward for a variety of factors. There are differences between pre- and postmortem diagnoses. Autopsies remain a tool for education, public health research, quality control, and closure for families. We report two cases that illustrate the utility of autopsy for uncovering contributing factors in the death of these patients and highlight their ongoing importance. Clinical and autopsy investigation of two individuals and illustration of the importance of autopsy findings which, had they been diagnosed premortem, could have changed the outcome. Cases were evaluated using the Goldman criteria for discrepancies between premortem clinical diagnoses and postmortem autopsy findings. In the first case, the patient had been previously admitted due to a non-ST elevation myocardial infarction months before the fatal event. The autopsy showed an undiagnosed clear cell carcinoma of the ovary. She expired due to a massive myocardial infarction secondary to neoplasm induced hypercoagulable state. The degree of pre-mortem/postmortem diagnostic discrepancy makes this a Goldman Class I error.In the second case, the patient presented to the emergency department with symptoms of Guillain-Barré Syndrome (GBS), for which he was treated. Abdominal masses were discovered; however, the patient decompensated before workup was completed. A high-grade B-cell lymphoma was confirmed but would not have altered the outcome, making this a Goldman class II error. The autopsy remains a relevant and necessary tool for physicians and society. It assists in the establishment of diagnoses, measurement of treatment quality, the providence of public health metrics, and closure to the survivors.

Sections du résumé

Background UNASSIGNED
Autopsy requests have been trending downward for a variety of factors. There are differences between pre- and postmortem diagnoses. Autopsies remain a tool for education, public health research, quality control, and closure for families.
Objective UNASSIGNED
We report two cases that illustrate the utility of autopsy for uncovering contributing factors in the death of these patients and highlight their ongoing importance.
Design UNASSIGNED
Clinical and autopsy investigation of two individuals and illustration of the importance of autopsy findings which, had they been diagnosed premortem, could have changed the outcome. Cases were evaluated using the Goldman criteria for discrepancies between premortem clinical diagnoses and postmortem autopsy findings.
Results UNASSIGNED
In the first case, the patient had been previously admitted due to a non-ST elevation myocardial infarction months before the fatal event. The autopsy showed an undiagnosed clear cell carcinoma of the ovary. She expired due to a massive myocardial infarction secondary to neoplasm induced hypercoagulable state. The degree of pre-mortem/postmortem diagnostic discrepancy makes this a Goldman Class I error.In the second case, the patient presented to the emergency department with symptoms of Guillain-Barré Syndrome (GBS), for which he was treated. Abdominal masses were discovered; however, the patient decompensated before workup was completed. A high-grade B-cell lymphoma was confirmed but would not have altered the outcome, making this a Goldman class II error.
Conclusions UNASSIGNED
The autopsy remains a relevant and necessary tool for physicians and society. It assists in the establishment of diagnoses, measurement of treatment quality, the providence of public health metrics, and closure to the survivors.

Identifiants

pubmed: 37292388
doi: 10.4322/acr.2023.425
pii: acrep159523
pmc: PMC10247289
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e2023425

Informations de copyright

Copyright: © 2023 The Authors.

Déclaration de conflit d'intérêts

Conflict of interest: None.

Références

Mo Med. 2010 Mar-Apr;107(2):94-100
pubmed: 20446515
Clin Adv Hematol Oncol. 2010 Mar;8(3):201-3
pubmed: 20400935
J Neurooncol. 1998 Jun-Jul;38(2-3):245-52
pubmed: 9696379
Lancet. 2021 Mar 27;397(10280):1214-1228
pubmed: 33647239
PLoS One. 2021 Aug 13;16(8):e0255490
pubmed: 34388154
Autops Case Rep. 2017 Dec 8;7(4):1-2
pubmed: 29259925
Continuum (Minneap Minn). 2020 Oct;26(5):1184-1204
pubmed: 33002998
J Cardiol. 2018 Aug;72(2):89-93
pubmed: 29588087
N Engl J Med. 1983 Apr 28;308(17):1000-5
pubmed: 6835306
Eur Respir Rev. 2019 Mar 27;28(151):
pubmed: 30918022
Am J Med. 1986 Apr;80(4):665-71
pubmed: 3963043
Cancers (Basel). 2022 Apr 24;14(9):
pubmed: 35565252
Arch Pathol Lab Med. 2017 Sep;141(9):1262-1266
pubmed: 28657772
Virchows Arch. 2021 Aug;479(2):385-392
pubmed: 33580806
Muscle Nerve. 2010 Jul;42(1):133-6
pubmed: 20544922

Auteurs

Alexia Vignau (A)

University of Miami Miller School of Medicine, Miami, FL, United States of America.

Clara Milikowski (C)

University of Miami Miller School of Medicine, Faculty Clara Milikowski, Department of Pathology, Miami, FL, United States of America.

Classifications MeSH